Pfizer and BioNTech's coronavirus vaccine enters human trials - Business Insider

Deutschland Nachrichten Nachrichten

Pfizer and BioNTech's coronavirus vaccine enters human trials - Business Insider
Deutschland Neuesten Nachrichten,Deutschland Schlagzeilen
  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 19 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 51%

ICYMI: Pfizer and BioNTech's potential vaccine for the coronavirus could be set for emergency use in the fall — well ahead of experts' predictions

a deal in mid-March in which Pfizer leveraged the German biotech's drug development platform and both companies utilized each other's research and development sites. The duo's vaccine for the novel coronavirus could be set for emergency use in the fall — well ahead of experts' predictions — with the potential for hundreds of millions of doses to be produced in 2021.

As biotechs showcase their ability to quickly develop novel vaccines, we expect to see pharmaceutical companies increasingly forge partnerships with them that could outlast the pandemic. The promise of BioNTech's recent work with Pfizer lies in biotech firms' research brawn and ability to develop vaccine candidates for novel diseases via technologies like AI.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

BusinessInsider /  🏆 729. in US

Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Pfizer aims for 10-20 million doses of coronavirus vaccine by end-2020Pfizer aims for 10-20 million doses of coronavirus vaccine by end-2020Pfizer aims to make 10-20 million doses of a coronavirus vaccine it is developing with Germany's BioNtech by the end of 2020 for emergency use should it pass tests, the U.S. drugmaker's head of vaccines said on Thursday.
Weiterlesen »

Pfizer aims for 10-20 million doses of coronavirus vaccine by end-2020Pfizer aims for 10-20 million doses of coronavirus vaccine by end-2020Pfizer aims to make 10-20 million doses of a coronavirus vaccine it is developing with Germany's BioNtech by the end of 2020 for emergency use should it pass tests, the U.S. drugmaker's head of vaccines said on Thursday.
Weiterlesen »

Bill Gates thinks there are 8 to 10 promising coronavirus vaccine candidates - Business InsiderBill Gates thinks there are 8 to 10 promising coronavirus vaccine candidates - Business InsiderGates touted the possibility of new RNA and DNA vaccines which could 'turn your body into its own vaccine manufacturing unit.'
Weiterlesen »

Bill Gates: 14 billion doses of coronavirus vaccines may be needed - Business InsiderBill Gates: 14 billion doses of coronavirus vaccines may be needed - Business Insider'We need to get them out to every part of the world, and we need all of this to happen as quickly as possible,' Gates said of a coronavirus vaccine.
Weiterlesen »

Oxford University developing coronavirus vaccine, says could be ready by year's endOxford University developing coronavirus vaccine, says could be ready by year's end'They are bid manufacturing immediately and on a massive scale,' RichardEngel reports on Oxford University's coronavirus vaccine. 'The CEO told me that they want to have, by year’s end, 100 million doses ready.'
Weiterlesen »

US health authorities will allow emergency use of Gilead's coronavirus treatment - Business InsiderUS health authorities will allow emergency use of Gilead's coronavirus treatment - Business InsiderThe coronavirus treatment just succeeded in a critical trial, helping severe COVID-19 patients recover faster.
Weiterlesen »



Render Time: 2025-04-08 08:25:55